ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

Audit Finds NIH Conflict of Interest Reports Scattered, Inaccessible, And Incomplete.

January 25, 2008

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

NCI Supercomputer Operations To Start In April

November 15, 1985